TuncaÇTaşADemirtaş İnciS. The role of the HALP score in determining the severity of lower extremity peripheral arterial disease. Vascular2025; 17085381251330370. DOI: 10.1177/17085381251330370.
2.
KaradumanABalabanİBiyiklıK, et al.Relationship of the modified Glasgow prognostic score with peripheral artery disease severity and procedure success in patients who had undergone endovascular treatment. Vascular2024; 17085381241273281. DOI: 10.1177/17085381241273281.
3.
EvsenAAktanAKılıçR, et al.Assessing the prognostic value of HALP score in peripheral artery disease: correlation with lesion severity and long-term mortality. Vascular2025; 17085381251327000 DOI: 10.1177/17085381251327000.
4.
RazzoukLRockmanCBPatelMR, et al.Co-existence of vascular disease in different arterial beds: peripheral artery disease and carotid artery stenosis--data from life line screening(®). Atherosclerosis2015; 241(2): 687–691.
5.
YanYGaoRZhangS, et al.Hemoglobin A1c and angiographic severity with coronary artery disease: a cross-sectional study. Int J Gen Med2022; 15: 1485–1495.
6.
LeelathanalerkAPiankarnkaNSrimongkonP, et al.Quality of life and utility of patients with peripheral artery disease (PAD): a systematic review and meta-analysis. Sci Rep2024; 14(1): 28823.
